Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck (Q43764068)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck |
scientific article |
Statements
1 reference
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck (English)
1 reference
Harrington KJ
1 reference
Lewanski C
1 reference
Northcote AD
1 reference
Whittaker J
1 reference
Peters AM
1 reference
Vile RG
1 reference
Stewart JS
1 reference
1 November 2001
1 reference
1 reference
37
1 reference
16
1 reference
2015-2022
1 reference
Identifiers
1 reference
1 reference